Profil
Mr. Owen Gordon is a Director-Finance & Corporate Development at Axela, Inc.
Mr. Gordon was previously employed as a Principal by Amgen Canada, Inc., a Principal by Bayer, Inc., a Principal by Eli Lilly Canada, Inc., and a Principal by Open Text Corp.
Anciens postes connus de Owen Gordon
| Sociétés | Poste | Fin |
|---|---|---|
| OPEN TEXT CORPORATION | Corporate Officer/Principal | - |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Corporate Officer/Principal | - |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Corporate Officer/Principal | - |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Corporate Officer/Principal | - |
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Develops biosensor technology | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Open Text Corp.
Open Text Corp. Packaged SoftwareTechnology Services Develops enterprise information management software | Technology Services |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Develops biosensor technology | Health Technology |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Health Technology |
















